EuroEyes International Surges with Over 14% Growth in Q4 2023

　　In a groundbreaking voluntary announcement on the Hong Kong Stock Exchange, EuroEyes International unveils a spectacular achievement in the fourth quarter of 2023. The number of eye operations conducted during this period has surged impressively, marking an extraordinary increase of over 14% when compared to the figures from 2022.

　　What makes this accomplishment even more compelling is EuroEyes' unique business model. Having achieved break-even and operating with low variable costs, each additional eye operation contributes substantially to the company's EBIT. This strategic advantage positions EuroEyes for substantial financial cash flow growth with every added procedure.

　　This stellar performance is a testament to EuroEyes' resilience and adaptability, persisting in the face of international turmoil and uncertainties, particularly amidst the crisis in Ukraine and elevated interest rates. Despite these challenges, EuroEyes International has not only maintained its momentum but has also continued the impressive growth trajectory witnessed throughout 2023.

　　For investors and stakeholders seeking further insights, detailed information is available in the official documentation released on the Hong Kong Stock Exchange platform. EuroEyes International remains committed to delivering exceptional eye care services while achieving remarkable financial success in a dynamic global landscape.